Lutetium chloride Lu-177 is a radioactive compound used mainly as a radiopharmaceutical precursor in targeted cancer therapy. On its own, it is not used directly for treatment, but it is combined with tumor-targeting molecules (like peptides or antibodies) to create radiolabeled drugs for theranostic (therapy + diagnostic) purposes. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include EndolucinBeta, Lumark and Illuzyce (TN). Its PubChem CID is 71587001.
Lutetium chloride Lu-177
| CAS No | 16434-14-3 |
|---|---|
| Molecular Formula | Cl3Lu |
| Molecular Weight | 283.30 g/mol |
| Synonyms | lutetium-177(3+);trichloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lutetium chloride Lu-177 is a radioactive compound used mainly as a radiopharmaceutical precursor in targeted cancer therapy.
The listed CAS number is 16434-14-3.
The listed molecular formula is Cl3Lu.
The listed molecular weight is 283.30 g/mol.
lutetium-177(3+);trichloride.
The source lists EndolucinBeta, Lumark and Illuzyce (TN).